Canada Legalizes Cannabinoid-Infused Beverages
This announcement was included in the approval and release of edits to Bill C-45 which also outlined a deadline stating that edibles will be available to the public, alongside the marijuana adult use legalization, set to launch in 2018.
Marijuana May Not be a Plausible Alternative to Opioid Drugs in Pain Treatment
Patients believe using marijuana helps them with their symptoms, but the study’s results could indicate the opposite is true for those in addiction treatment.
New Player Enters Californian Cannabis Testing Market
Formed by Sachin Barot and Denis Chen, the CERESLabs mission is to become the global leader in analytical cannabis product testing.
Trends in Medical Marijuana Use in Washington State
About 1 in 7 adult primary care patients visiting medical offices reported having used marijuana at least once in the past year.
Steep Hill, Eybna Partner to Commercialize Customized Cannabis Terpene Products
The partnership will utilize Steep Hill's expertise in analytical testing to customize Eybna's production of terpene formulations for optimizing the medical benefits of cannabis.
Taking Advantage of Canada’s Cannabis Testing Market
Third party lab testing isn’t currently required by Health Canada, but the agency has already required ‘expanded’ testing for licensed producers to ensure that pesticide and additive requirements are being met.
Steep Hill Expands Into Oregon
Jmîchaeĺe Keller, President and CEO of Steep Hill has announced that it has licensed its cannabis testing technology to highly respected pain and addiction physician Dr. Carl Balog.
Cannabis Medicine: Providing Patients with the Right Chemical Profile for Their Condition
Analyzing the complex chemistry of the cannabis plant may help scientists to develop specific cannabis-based drugs for specific conditions.
Tilray Takes Medical Cannabis to the EU
This is the first time a company has legally exported live cannabis genetics from North America to Europe.
